Kiehls Clearly Corrective Dark Spot Solution – 100 ml
Kiehl’s Clearly Corrective Dark Spot Solution is a targeted serum for uneven skin tone which helps in clearing skin and boosts radiance. Formulated with Activated C (a stabilized form of Vitamin C), buffered Salicylic Acid, and Peony extract, this efficacious brightening serum helps visibly reduce the appearance of a broad array of discolorations including dark spots, hyperpigmentation and post-acne marks. This facial serum for dark spots has been tested on all ethnicities and can be used as a facial serum for dry skin along with sensitive type
Paraben-free, mineral oil-free, and dye-free.
After using one bottle of our dark spot corrector: **
- 97% saw a visible reduction in hyperpigmentation
- 97% saw a visible reduction in dark spots
- 87% saw a visible reduction in post-acne marks
*This product was tested on a multi-ethnic panel equally distributed: 25% African American, 25% Asian, 25% Caucasian, 25% Hispanic
**Results based on expert grading in a 12-week clinical test on 104 subjects.
Kiehls Clearly Corrective Dark Spot Solution – 100 ml
Kiehl’s Clearly Corrective Dark Spot Solution is a targeted serum for uneven skin tone which helps in clearing skin and boosts radiance. Formulated with Activated C (a stabilized form of Vitamin C), buffered Salicylic Acid, and Peony extract, this efficacious brightening serum helps visibly reduce the appearance of a broad array of discolorations including dark spots, hyperpigmentation and post-acne marks. This facial serum for dark spots has been tested on all ethnicities and can be used as a facial serum for dry skin along with sensitive type
Paraben-free, mineral oil-free, and dye-free.
After using one bottle of our dark spot corrector: **
- 97% saw a visible reduction in hyperpigmentation
- 97% saw a visible reduction in dark spots
- 87% saw a visible reduction in post-acne marks
*This product was tested on a multi-ethnic panel equally distributed: 25% African American, 25% Asian, 25% Caucasian, 25% Hispanic
**Results based on expert grading in a 12-week clinical test on 104 subjects.